Cerebral Angiography Market Size to Hit USD 2.07 Billion by 2033

Cerebral Angiography Market Size, Share, Growth, By Type (Digital Subtraction Angiography – DSA; Magnetic Resonance Angiography – MRA; Computed Tomography Angiography – CTA; Ultrasound Angiography; X-Ray/Conventional Angiography), By Product (Angiography Systems & Equipment, Contrast Media/Dyes, Catheters & Guidewires, Sheaths & Introducers, Software & Workstations, Others), By Application (Stroke & TIA Diagnosis, Brain Tumor Detection, Arteriovenous Malformation – AVM; Cerebral Aneurysm Assessment, Atherosclerosis Evaluation, Pre-Surgical Planning, Others), By End User (Hospitals & Neurology Centers, Diagnostic Imaging Centers, Specialty Clinics & Catheterization Labs, Academic & Research Institutes), By Modality (Invasive Cerebral Angiography, Non-Invasive Cerebral Angiography), By Region (North America – U.S., Canada, Mexico; Europe – Germany, UK, France, Italy, Netherlands, Spain, Rest of Europe; Asia Pacific – China, India, Japan, South Korea, Australia, Rest of Asia Pacific; Latin America – Brazil, Argentina, Rest of Latin America; Middle East & Africa – GCC Countries, South Africa, Rest of MEA) and Market Forecast, 2026 – 2033

  • Published: May, 2026
  • Report ID: 1024
  • Pages: 180+
  • Format: PDF / Excel.

This report contains the Latest Market Figures, Statistics, and Data.

Get a Sample
logo

Cerebral Angiography Market Size to Hit USD 2.07 Billion by 2033

(An Updated Version is Available)

1. Preface

  • 1.1 Report Description and Scope

  • 1.2 Research Objective

  • 1.3 Key Market Segmentation Overview

  • 1.4 Years Considered for the Study

  • 1.5 Currency Used in the Report

  • 1.6 Key Benefits for Stakeholders

  • 1.7 Target Audience

2. Research Methodology

  • 2.1 Research Design and Approach

  • 2.2 Data Sources

  • 2.3 Primary Research

  • 2.4 Secondary Research

  • 2.5 Market Estimation Techniques

    • 2.5.1 Bottom-Up Approach

    • 2.5.2 Top-Down Approach

  • 2.6 Data Triangulation and Validation

  • 2.7 Forecasting Methodology

  • 2.8 Assumptions and Limitations

3. Executive Summary

  • 3.1 Global Cerebral Angiography Market Snapshot (2026–2033)

  • 3.2 Key Findings and Strategic Insights

  • 3.3 Analyst Recommendations

4. Market Overview

  • 4.1 Introduction, Definition, and Scope

  • 4.2 Market Classification and Taxonomy

  • 4.3 Market Evolution and Historical Context

  • 4.4 Industry Introduction — Cerebral Angiography Procedure Overview

    • 4.4.1 Principles of Contrast-Enhanced X-Ray Cerebrovascular Visualization

    • 4.4.2 Role of Cerebral Angiography in Neurovascular Diagnostics and Interventional Neurology

    • 4.4.3 Comparison with Alternative Neuroimaging Modalities (MRI, CT, PET, Doppler Ultrasound)

  • 4.5 Technology Landscape

    • 4.5.1 Digital Subtraction Angiography (DSA) — Gold Standard and Next-Generation Platforms

    • 4.5.2 3D Rotational Angiography and Cone-Beam CT Integration

    • 4.5.3 Flat-Panel Detector Systems and High-Resolution Biplane Imaging

    • 4.5.4 AI and Machine Learning Integration in Image Reconstruction and Workflow Automation

    • 4.5.5 Hybrid Imaging Systems (Angiography + CT / MRI Integration)

    • 4.5.6 Robotic-Assisted Endovascular Navigation and Remote Angiography Platforms

    • 4.5.7 Low-Dose Radiation Optimization Technologies and Dose Reduction Protocols

  • 4.6 Value Chain Analysis

    • 4.6.1 Raw Material Sourcing (Imaging Hardware Components, Contrast Media Ingredients, Catheter Materials)

    • 4.6.2 System and Device Manufacturing (Angiography Systems, Catheters, Guidewires, Accessories)

    • 4.6.3 Regulatory Approval, Clinical Validation, and GMP Compliance

    • 4.6.4 Distribution, Hospital Procurement, and Service Networks

    • 4.6.5 End-Use Integration (Hospitals, Diagnostic Imaging Centers, Neurology Clinics, ASCs)

  • 4.7 Supply Chain Analysis

  • 4.8 Porter's Five Forces Analysis

    • 4.8.1 Bargaining Power of Buyers

    • 4.8.2 Bargaining Power of Suppliers

    • 4.8.3 Threat of New Entrants

    • 4.8.4 Threat of Substitutes

    • 4.8.5 Competitive Rivalry

  • 4.9 Pricing Analysis and Trends

  • 4.10 Patent Landscape Analysis

  • 4.11 Regulatory Framework and Global Compliance Landscape

    • 4.11.1 FDA 510(k) Clearance and De Novo Pathway Requirements (U.S.)

    • 4.11.2 EU MDR 2017/745 Compliance and CE Marking

    • 4.11.3 Reimbursement Policies and Coverage Landscape (U.S., Europe, Asia Pacific)

    • 4.11.4 Country-Level Regulatory Standards in Asia Pacific and Emerging Markets

  • 4.12 Trade Data Analysis (Import/Export Dynamics)

  • 4.13 Impact of AI, Deep Learning, and Digital Imaging Technologies on Cerebral Angiography

  • 4.14 Impact of Macroeconomic and Geopolitical Factors

  • 4.15 Healthcare Infrastructure Growth, Installed Base, and New Technology Penetration

5. Market Trends and Success Factors

  • 5.1 Macro-Economic Factors Influencing Market Expansion

  • 5.2 Key Market Trends

    • 5.2.1 Shift Toward Minimally Invasive and Catheter-Based Angiographic Procedures

    • 5.2.2 Growing Adoption of AI-Assisted Imaging for Automated Vessel Detection and Lesion Identification

    • 5.2.3 Rapid Expansion of Cerebral Angiography in Acute Stroke Pathway Management

    • 5.2.4 Integration of Advanced Flat-Panel Detectors for Higher Resolution and Reduced Radiation

    • 5.2.5 Rise of Hybrid Imaging Systems Combining Angiography with CT and MRI

    • 5.2.6 Increasing Use of Robotic Navigation Platforms for Precision Endovascular Intervention

  • 5.3 Recent Industry Developments (2024–2026)

    • 5.3.1 Product Launches and Portfolio Expansions

    • 5.3.2 Mergers, Acquisitions, and Strategic Collaborations

    • 5.3.3 Regulatory Clearances and New Product Approvals

6. Market Dynamics

  • 6.1 Overview of Market Dynamics

  • 6.2 Drivers

    • 6.2.1 Rising Global Incidence of Stroke, Cerebral Aneurysms, and Arteriovenous Malformations (AVMs)

    • 6.2.2 Increasing Prevalence of Cerebrovascular and Neurovascular Diseases Globally

    • 6.2.3 Advancements in Imaging Technology — DSA, Flat-Panel Detectors, and 3D Rotational Angiography

    • 6.2.4 Growing Geriatric Population Driving Higher Demand for Neurovascular Diagnostics

    • 6.2.5 Expansion of Comprehensive Stroke Centers and Neurointerventional Radiology Units

    • 6.2.6 Growing Demand for Minimally Invasive Interventional Neurology Procedures

    • 6.2.7 Supportive Reimbursement Policies Across North America and Europe

  • 6.3 Restraints

    • 6.3.1 High Cost of Cerebral Angiography Systems and Associated Procedure Expenses

    • 6.3.2 Potential Risks and Complications (Contrast Agent Reactions, Radiation, Catheter-Related Events)

    • 6.3.3 Availability of Non-Invasive Alternative Imaging Modalities (CTA, MRA)

    • 6.3.4 Shortage of Skilled Operators — Trained Neurointerventionalists and Interventional Radiologists

  • 6.4 Opportunities

    • 6.4.1 Integration of AI and ML for Automated Image Analysis, Workflow Optimization, and Clinical Decision Support

    • 6.4.2 Expansion of Ambulatory Surgical Centers (ASCs) and Outpatient Neuroimaging Settings

    • 6.4.3 Growing Healthcare Infrastructure in Asia Pacific, Latin America, and MEA

    • 6.4.4 Rising Medical Tourism and Cross-Border Neurovascular Care Demand

    • 6.4.5 Collaboration Between Medical Device Companies and Academic Stroke Centers

  • 6.5 Challenges

    • 6.5.1 Ensuring Standardization of Angiographic Protocols Across Multi-Center and Multi-Country Settings

    • 6.5.2 Managing Radiation Exposure Risks and Compliance with Evolving Regulatory Standards

    • 6.5.3 Increasing Competition from Non-Invasive Imaging and CTA/MRA Platforms

7. COVID-19 Impact Analysis

  • 7.1 Pre-COVID-19 Market Outlook

  • 7.2 Impact of COVID-19 on the Cerebral Angiography Market

  • 7.3 Post-COVID-19 Recovery Trajectory and Demand Restoration

  • 7.4 Long-Term Behavioral Shifts in Neurovascular Diagnostics Procurement and Care Delivery

8. Global Cerebral Angiography Market — By Product Type

  • 8.1 Overview and Key Findings

  • 8.2 Cerebral Angiography Systems

    • 8.2.1 Single-Plane Angiography Systems

    • 8.2.2 Biplane Angiography Systems

    • 8.2.3 Hybrid Angiography Systems (Angio + CT / Angio + MRI)

    • 8.2.4 Market Trends and Revenue Share Analysis

    • 8.2.5 Revenue Growth Opportunity

  • 8.3 Angiography Catheters

    • 8.3.1 Diagnostic Catheters

    • 8.3.2 Balloon Catheters

    • 8.3.3 Micro-Catheters

    • 8.3.4 Market Trends and Revenue Share Analysis

    • 8.3.5 Revenue Growth Opportunity

  • 8.4 Guidewires

    • 8.4.1 Market Trends and Revenue Share Analysis

    • 8.4.2 Revenue Growth Opportunity

  • 8.5 Contrast Media

    • 8.5.1 Iodinated Contrast Agents

    • 8.5.2 Gadolinium-Based Contrast Agents (for MRA)

    • 8.5.3 Market Trends and Revenue Share Analysis

    • 8.5.4 Revenue Growth Opportunity

  • 8.6 Accessories and Consumables (Sheaths, Manifolds, Syringes, Hemostasis Devices)

    • 8.6.1 Market Trends and Revenue Share Analysis

    • 8.6.2 Revenue Growth Opportunity

9. Global Cerebral Angiography Market — By Technology / Imaging Technique

  • 9.1 Overview and Key Findings

  • 9.2 Digital Subtraction Angiography (DSA)

    • 9.2.1 Market Trends and Demand Drivers

    • 9.2.2 Revenue Share Analysis

    • 9.2.3 Revenue Growth Opportunity

  • 9.3 Computed Tomography Angiography (CTA)

    • 9.3.1 Market Trends and Demand Drivers

    • 9.3.2 Revenue Share Analysis

    • 9.3.3 Revenue Growth Opportunity

  • 9.4 Magnetic Resonance Angiography (MRA)

    • 9.4.1 Market Trends and Demand Drivers

    • 9.4.2 Revenue Share Analysis

    • 9.4.3 Revenue Growth Opportunity

  • 9.5 Catheter-Based Angiography

    • 9.5.1 Market Trends and Demand Drivers

    • 9.5.2 Revenue Share Analysis

    • 9.5.3 Revenue Growth Opportunity

  • 9.6 Intraoperative Angiography

    • 9.6.1 Market Trends and Demand Drivers

    • 9.6.2 Revenue Share Analysis

    • 9.6.3 Revenue Growth Opportunity

  • 9.7 Other Advanced Imaging Techniques (3D Rotational Angiography, Cone-Beam CT)

    • 9.7.1 Market Trends and Demand Drivers

    • 9.7.2 Revenue Share Analysis

    • 9.7.3 Revenue Growth Opportunity

10. Global Cerebral Angiography Market — By Procedure Type

  • 10.1 Overview and Key Findings

  • 10.2 Diagnostic Cerebral Angiography

    • 10.2.1 Market Trends and Revenue Share Analysis

    • 10.2.2 Revenue Growth Opportunity

  • 10.3 Interventional Cerebral Angiography

    • 10.3.1 Endovascular Coiling and Stent-Assisted Coiling

    • 10.3.2 Mechanical Thrombectomy

    • 10.3.3 AVM Embolization

    • 10.3.4 Carotid Stenting and Angioplasty

    • 10.3.5 Market Trends and Revenue Share Analysis

    • 10.3.6 Revenue Growth Opportunity

11. Global Cerebral Angiography Market — By Indication

  • 11.1 Overview and Key Findings

  • 11.2 Stroke (Ischemic and Hemorrhagic)

    • 11.2.1 Market Trends and Revenue Share Analysis

    • 11.2.2 Revenue Growth Opportunity

  • 11.3 Intracranial Aneurysms

    • 11.3.1 Market Trends and Revenue Share Analysis

    • 11.3.2 Revenue Growth Opportunity

  • 11.4 Arteriovenous Malformations (AVMs)

    • 11.4.1 Market Trends and Revenue Share Analysis

    • 11.4.2 Revenue Growth Opportunity

  • 11.5 Cerebrovascular Disease and Stenosis

    • 11.5.1 Market Trends and Revenue Share Analysis

    • 11.5.2 Revenue Growth Opportunity

  • 11.6 Cerebral Tumors and Tumor Vascularity Assessment

    • 11.6.1 Market Trends and Revenue Share Analysis

    • 11.6.2 Revenue Growth Opportunity

  • 11.7 Carotid Artery Disease

    • 11.7.1 Market Trends and Revenue Share Analysis

    • 11.7.2 Revenue Growth Opportunity

  • 11.8 Others (Dural Fistulas, Vasculitis, Pediatric Neurovascular Conditions)

    • 11.8.1 Market Trends and Revenue Share Analysis

    • 11.8.2 Revenue Growth Opportunity

12. Global Cerebral Angiography Market — By Patient Age Group

  • 12.1 Overview and Key Findings

  • 12.2 Adult Patients

    • 12.2.1 Market Trends and Revenue Share Analysis

    • 12.2.2 Revenue Growth Opportunity

  • 12.3 Pediatric Patients

    • 12.3.1 Market Trends and Revenue Share Analysis

    • 12.3.2 Revenue Growth Opportunity

13. Global Cerebral Angiography Market — By End User

  • 13.1 Overview and Key Findings

  • 13.2 Hospitals

    • 13.2.1 Comprehensive Stroke Centers

    • 13.2.2 Tertiary and Multi-Specialty Hospitals

    • 13.2.3 Market Trends and Revenue Share Analysis

    • 13.2.4 Revenue Growth Opportunity

  • 13.3 Diagnostic Imaging Centers

    • 13.3.1 Market Trends and Revenue Share Analysis

    • 13.3.2 Revenue Growth Opportunity

  • 13.4 Specialty Neurology Clinics

    • 13.4.1 Market Trends and Revenue Share Analysis

    • 13.4.2 Revenue Growth Opportunity

  • 13.5 Ambulatory Surgical Centers (ASCs)

    • 13.5.1 Market Trends and Revenue Share Analysis

    • 13.5.2 Revenue Growth Opportunity

  • 13.6 Academic and Research Institutions

    • 13.6.1 Market Trends and Revenue Share Analysis

    • 13.6.2 Revenue Growth Opportunity

  • 13.7 Others (Veterinary Clinics, Defense Healthcare Facilities)

    • 13.7.1 Market Trends and Revenue Share Analysis

    • 13.7.2 Revenue Growth Opportunity

14. Global Cerebral Angiography Market — Cross-Segment Analysis

  • 14.1 Product Type × Technology Analysis

  • 14.2 Indication × Procedure Type Analysis

  • 14.3 Technology × End User Analysis

  • 14.4 Patient Age Group × Indication Analysis

15. Global Cerebral Angiography Market — Regional Analysis

  • 15.1 Regional Overview and Key Insights

  • 15.2 North America

    • 15.2.1 Market Overview and Trends

    • 15.2.2 United States

    • 15.2.3 Canada

    • 15.2.4 Mexico

  • 15.3 Europe

    • 15.3.1 Market Overview and Trends

    • 15.3.2 Germany

    • 15.3.3 United Kingdom

    • 15.3.4 France

    • 15.3.5 Italy

    • 15.3.6 Spain

    • 15.3.7 Russia

    • 15.3.8 Netherlands

    • 15.3.9 Switzerland

    • 15.3.10 Belgium

    • 15.3.11 Turkey

    • 15.3.12 Rest of Europe

  • 15.4 Asia Pacific

    • 15.4.1 Market Overview and Trends

    • 15.4.2 China

    • 15.4.3 Japan

    • 15.4.4 India

    • 15.4.5 South Korea

    • 15.4.6 Australia

    • 15.4.7 Singapore

    • 15.4.8 Malaysia

    • 15.4.9 Thailand

    • 15.4.10 Indonesia

    • 15.4.11 Philippines

    • 15.4.12 Rest of Asia Pacific

  • 15.5 Latin America (South & Central America)

    • 15.5.1 Market Overview and Trends

    • 15.5.2 Brazil

    • 15.5.3 Argentina

    • 15.5.4 Mexico

    • 15.5.5 Rest of Latin America

  • 15.6 Middle East & Africa

    • 15.6.1 Market Overview and Trends

    • 15.6.2 Saudi Arabia

    • 15.6.3 UAE

    • 15.6.4 Israel

    • 15.6.5 Egypt

    • 15.6.6 South Africa

    • 15.6.7 Rest of Middle East & Africa

16. Competitive Landscape

  • 16.1 Market Competition Overview

  • 16.2 Market Share Analysis (2026)

  • 16.3 Competitive Positioning Matrix

  • 16.4 Heat Map Analysis

  • 16.5 Key Strategies Adopted by Leading Players

    • 16.5.1 New Product Launches and Imaging System Upgrades

    • 16.5.2 Strategic Acquisitions, Licensing, and Cross-Specialty Collaborations

    • 16.5.3 Clinical Evidence Generation and Regulatory Approval Strategies

    • 16.5.4 AI Integration and Digital Neurovascular Workflow Expansion

    • 16.5.5 Geographic Expansion into Asia Pacific, Latin America, and MEA

  • 16.6 Industry Landscape — Organic and Inorganic Growth Strategies

    • 16.6.1 Overview of Organic Developments

    • 16.6.2 Overview of Inorganic Developments

  • 16.7 Recent Industry Developments (2024–2026)

  • 16.8 Startup and Emerging Player Ecosystem

  • 16.9 Investment and Funding Landscape

17. SWOT Analysis

  • 17.1 Overview

  • 17.2 Strengths

  • 17.3 Weaknesses

  • 17.4 Opportunities

  • 17.5 Threats

18. Company Profiles (The final report includes a complete list of companies)

  • 18.1 Siemens Healthineers AG (Germany)

    • 18.1.1 Company Overview

    • 18.1.2 Financial Performance

    • 18.1.3 Product Portfolio

    • 18.1.4 Strategic Initiatives

    • 18.1.5 SWOT Analysis

  • 18.2 GE HealthCare (U.S.)

  • 18.3 Koninklijke Philips N.V. (Netherlands)

  • 18.4 Canon Medical Systems Corporation (Japan)

  • 18.5 Shimadzu Corporation (Japan)

  • 18.6 Medtronic plc (Ireland/U.S.)

  • 18.7 Stryker Corporation (U.S.)

  • 18.8 Terumo Corporation (Japan)

  • 18.9 Boston Scientific Corporation (U.S.)

  • 18.10 AngioDynamics, Inc. (U.S.)

  • 18.11 Penumbra, Inc. (U.S.)

  • 18.12 MicroPort Scientific Corporation (China)

  • 18.13 Cook Medical LLC (U.S.)

  • 18.14 Cordis (U.S.)

  • 18.15 Abbott Laboratories (U.S.)

19. Emerging Trends and Future Outlook

  • 19.1 AI-Powered Automated Vessel Detection, Lesion Identification, and Angiographic Workflow Automation

  • 19.2 Next-Generation Flat-Panel Detector Systems and Radiation Dose Reduction Innovations

  • 19.3 Rise of Robotic-Assisted Endovascular Navigation and Remote Angiography Platforms

  • 19.4 Integration of Real-Time 3D Rotational Angiography and Cone-Beam CT in Neurointerventional Suites

  • 19.5 Expansion of Cerebral Angiography in Outpatient, Ambulatory, and Specialty Neurology Settings

  • 19.6 Regulatory Harmonization and Global Reimbursement Policy Evolution

  • 19.7 Growing Role of Medical Tourism and Cross-Border Cerebrovascular Care

  • 19.8 Development of Next-Generation Low-Toxicity and AI-Optimized Contrast Media

  • 19.9 Expansion of Comprehensive Stroke Centers and Neurointerventional Radiology Globally

20. Appendix

  • 20.1 Research Methodology Details

  • 20.2 List of Abbreviations

  • 20.3 Data Sources and References

  • 20.4 Glossary of Terms

  • 20.5 List of Tables

  • 20.6 List of Figures

21. Disclaimer

Enhance your decision-making capabilities with a 5 Reports-in-1
Bundle deal for - more than 40% off!

Our professional analysts will provide you with immediate assistance.